The Will Erwin Headache Research Center - Cluster Headache Study
Key facts
- Where
- Houston, United StatesSee the site
Where in United States
- The University of Texas Health Science Center at HoustonHouston, United StatesContact: Rebecca Martinez, RNTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- The University of Texas Health Science Center, Houston
- Trial code
- NCT02910323
- Record updated
- 18 February 2026
- Original description
The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.Read full original descriptionShow less
The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia
The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.
Inclusion: Diagnosis of a trigeminal autonomic cephalalgia according to the International Headache Classification including episodic cluster headache, chronic cluster headache, episodic paroxysmal hemicrania, chronic paroxysmal hemicrania, episodic short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), chronic SUNCT, episodic short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), chronic SUNA, and hemicrania continua. OR Diagnosis of a trigeminal neuralgia according to the International Headache Classification, including classical trigeminal neuralgia and symptomatic trigeminal neuralgia; Able to provide HIPAA authorization to share prior medical records/imaging; Inclusion criteria is willingness to consent and be of age 18 and older.
Exclusion: Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements; Life expectancy less than 1 year, co-existing disease or other characteristic that precludes appropriate diagnosis of a trigeminal autonomic cephalalgia or trigeminal neuralgia; Inability or unwillingness of subject or legal guardian/representative to give informed consent.